nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP2C19—Prednisone—ankylosing spondylitis	0.0852	0.171	CbGbCtD
Bromazepam—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0848	0.171	CbGbCtD
Bromazepam—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.068	0.137	CbGbCtD
Bromazepam—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0532	0.107	CbGbCtD
Bromazepam—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0515	0.104	CbGbCtD
Bromazepam—CYP3A4—Betamethasone—ankylosing spondylitis	0.0442	0.0888	CbGbCtD
Bromazepam—CYP3A4—Prednisolone—ankylosing spondylitis	0.0436	0.0877	CbGbCtD
Bromazepam—CYP3A4—Prednisone—ankylosing spondylitis	0.0412	0.0828	CbGbCtD
Bromazepam—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0257	0.0517	CbGbCtD
Bromazepam—Multiple fractures—Methylprednisolone—ankylosing spondylitis	0.00871	0.0204	CcSEcCtD
Bromazepam—Fracture—Methylprednisolone—ankylosing spondylitis	0.00871	0.0204	CcSEcCtD
Bromazepam—Fracture—Dexamethasone—ankylosing spondylitis	0.00792	0.0186	CcSEcCtD
Bromazepam—Fracture—Betamethasone—ankylosing spondylitis	0.00792	0.0186	CcSEcCtD
Bromazepam—Multiple fractures—Betamethasone—ankylosing spondylitis	0.00792	0.0186	CcSEcCtD
Bromazepam—Multiple fractures—Dexamethasone—ankylosing spondylitis	0.00792	0.0186	CcSEcCtD
Bromazepam—Delusion—Methylprednisolone—ankylosing spondylitis	0.00715	0.0168	CcSEcCtD
Bromazepam—Fracture—Prednisone—ankylosing spondylitis	0.0069	0.0162	CcSEcCtD
Bromazepam—Multiple fractures—Prednisone—ankylosing spondylitis	0.0069	0.0162	CcSEcCtD
Bromazepam—Delusion—Dexamethasone—ankylosing spondylitis	0.0065	0.0153	CcSEcCtD
Bromazepam—Delusion—Betamethasone—ankylosing spondylitis	0.0065	0.0153	CcSEcCtD
Bromazepam—Fracture—Methotrexate—ankylosing spondylitis	0.00576	0.0135	CcSEcCtD
Bromazepam—Multiple fractures—Methotrexate—ankylosing spondylitis	0.00576	0.0135	CcSEcCtD
Bromazepam—Delusion—Prednisone—ankylosing spondylitis	0.00566	0.0133	CcSEcCtD
Bromazepam—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00474	0.0111	CcSEcCtD
Bromazepam—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00436	0.0102	CcSEcCtD
Bromazepam—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00435	0.0102	CcSEcCtD
Bromazepam—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00395	0.00928	CcSEcCtD
Bromazepam—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00395	0.00928	CcSEcCtD
Bromazepam—GABRQ—Orphan transporters—ANO6—ankylosing spondylitis	0.00391	0.0512	CbGpPWpGaD
Bromazepam—Speech disorder—Methotrexate—ankylosing spondylitis	0.00389	0.00914	CcSEcCtD
Bromazepam—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00381	0.00893	CcSEcCtD
Bromazepam—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00376	0.00883	CcSEcCtD
Bromazepam—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00359	0.00842	CcSEcCtD
Bromazepam—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00353	0.00828	CcSEcCtD
Bromazepam—Irritability—Methylprednisolone—ankylosing spondylitis	0.00351	0.00823	CcSEcCtD
Bromazepam—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.0035	0.00821	CcSEcCtD
Bromazepam—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00349	0.0082	CcSEcCtD
Bromazepam—Euphoric mood—Prednisone—ankylosing spondylitis	0.00344	0.00808	CcSEcCtD
Bromazepam—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00342	0.00803	CcSEcCtD
Bromazepam—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00342	0.00803	CcSEcCtD
Bromazepam—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00326	0.00765	CcSEcCtD
Bromazepam—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00326	0.00765	CcSEcCtD
Bromazepam—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00325	0.00762	CcSEcCtD
Bromazepam—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00324	0.0076	CcSEcCtD
Bromazepam—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00323	0.00759	CcSEcCtD
Bromazepam—GABRG3—Orphan transporters—ANO6—ankylosing spondylitis	0.00322	0.0422	CbGpPWpGaD
Bromazepam—Irritability—Dexamethasone—ankylosing spondylitis	0.00319	0.00748	CcSEcCtD
Bromazepam—Irritability—Betamethasone—ankylosing spondylitis	0.00319	0.00748	CcSEcCtD
Bromazepam—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00318	0.00745	CcSEcCtD
Bromazepam—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00318	0.00745	CcSEcCtD
Bromazepam—GABRB1—Orphan transporters—ANO6—ankylosing spondylitis	0.00317	0.0416	CbGpPWpGaD
Bromazepam—GABRA6—Orphan transporters—ANO6—ankylosing spondylitis	0.003	0.0393	CbGpPWpGaD
Bromazepam—Cardiac failure—Prednisone—ankylosing spondylitis	0.00298	0.00699	CcSEcCtD
Bromazepam—GABRA4—Orphan transporters—ANO6—ankylosing spondylitis	0.00296	0.0388	CbGpPWpGaD
Bromazepam—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00295	0.00691	CcSEcCtD
Bromazepam—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00295	0.00691	CcSEcCtD
Bromazepam—GABRR1—Ion channel transport—ANO6—ankylosing spondylitis	0.00287	0.0377	CbGpPWpGaD
Bromazepam—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00284	0.00667	CcSEcCtD
Bromazepam—Irritability—Prednisone—ankylosing spondylitis	0.00278	0.00651	CcSEcCtD
Bromazepam—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00277	0.00649	CcSEcCtD
Bromazepam—GABRQ—Ion channel transport—ANO6—ankylosing spondylitis	0.00274	0.0359	CbGpPWpGaD
Bromazepam—GABRR2—Ion channel transport—ANO6—ankylosing spondylitis	0.00274	0.0359	CbGpPWpGaD
Bromazepam—GABRB2—Orphan transporters—ANO6—ankylosing spondylitis	0.00271	0.0355	CbGpPWpGaD
Bromazepam—GABRA5—Orphan transporters—ANO6—ankylosing spondylitis	0.00263	0.0345	CbGpPWpGaD
Bromazepam—GABRA3—Orphan transporters—ANO6—ankylosing spondylitis	0.00258	0.0339	CbGpPWpGaD
Bromazepam—Muscular weakness—Prednisone—ankylosing spondylitis	0.00257	0.00602	CcSEcCtD
Bromazepam—GABRA2—Orphan transporters—ANO6—ankylosing spondylitis	0.00254	0.0333	CbGpPWpGaD
Bromazepam—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00253	0.00593	CcSEcCtD
Bromazepam—GABRB3—Orphan transporters—ANO6—ankylosing spondylitis	0.00252	0.0331	CbGpPWpGaD
Bromazepam—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.0025	0.00586	CcSEcCtD
Bromazepam—GABRG2—Orphan transporters—ANO6—ankylosing spondylitis	0.00248	0.0325	CbGpPWpGaD
Bromazepam—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00238	0.00557	CcSEcCtD
Bromazepam—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00236	0.00553	CcSEcCtD
Bromazepam—Irritability—Methotrexate—ankylosing spondylitis	0.00232	0.00544	CcSEcCtD
Bromazepam—Hallucination—Dexamethasone—ankylosing spondylitis	0.0023	0.0054	CcSEcCtD
Bromazepam—Hallucination—Betamethasone—ankylosing spondylitis	0.0023	0.0054	CcSEcCtD
Bromazepam—Ataxia—Methotrexate—ankylosing spondylitis	0.00229	0.00536	CcSEcCtD
Bromazepam—Vision blurred—Prednisolone—ankylosing spondylitis	0.00227	0.00533	CcSEcCtD
Bromazepam—GABRG3—Ion channel transport—ANO6—ankylosing spondylitis	0.00226	0.0296	CbGpPWpGaD
Bromazepam—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00223	0.00522	CcSEcCtD
Bromazepam—GABRB1—Ion channel transport—ANO6—ankylosing spondylitis	0.00222	0.0291	CbGpPWpGaD
Bromazepam—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00221	0.00519	CcSEcCtD
Bromazepam—GABRA1—Orphan transporters—ANO6—ankylosing spondylitis	0.00217	0.0284	CbGpPWpGaD
Bromazepam—Eye disorder—Betamethasone—ankylosing spondylitis	0.00216	0.00507	CcSEcCtD
Bromazepam—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00216	0.00507	CcSEcCtD
Bromazepam—GABRA6—Ion channel transport—ANO6—ankylosing spondylitis	0.0021	0.0276	CbGpPWpGaD
Bromazepam—Convulsion—Prednisolone—ankylosing spondylitis	0.00209	0.0049	CcSEcCtD
Bromazepam—GABRA4—Ion channel transport—ANO6—ankylosing spondylitis	0.00208	0.0272	CbGpPWpGaD
Bromazepam—Hallucination—Prednisone—ankylosing spondylitis	0.002	0.0047	CcSEcCtD
Bromazepam—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00198	0.00464	CcSEcCtD
Bromazepam—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00197	0.00462	CcSEcCtD
Bromazepam—Convulsion—Triamcinolone—ankylosing spondylitis	0.00192	0.00451	CcSEcCtD
Bromazepam—Tachycardia—Prednisolone—ankylosing spondylitis	0.00192	0.00451	CcSEcCtD
Bromazepam—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00192	0.0045	CcSEcCtD
Bromazepam—GABRB2—Ion channel transport—ANO6—ankylosing spondylitis	0.0019	0.0249	CbGpPWpGaD
Bromazepam—Eye disorder—Prednisone—ankylosing spondylitis	0.00188	0.00441	CcSEcCtD
Bromazepam—Drowsiness—Methotrexate—ankylosing spondylitis	0.00187	0.0044	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00187	0.00439	CcSEcCtD
Bromazepam—GABRA5—Ion channel transport—ANO6—ankylosing spondylitis	0.00185	0.0242	CbGpPWpGaD
Bromazepam—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00185	0.00433	CcSEcCtD
Bromazepam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00182	0.00427	CcSEcCtD
Bromazepam—GABRA3—Ion channel transport—ANO6—ankylosing spondylitis	0.00181	0.0238	CbGpPWpGaD
Bromazepam—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00181	0.00425	CcSEcCtD
Bromazepam—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00181	0.00424	CcSEcCtD
Bromazepam—GABRA2—Ion channel transport—ANO6—ankylosing spondylitis	0.00178	0.0234	CbGpPWpGaD
Bromazepam—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00177	0.00415	CcSEcCtD
Bromazepam—GABRB3—Ion channel transport—ANO6—ankylosing spondylitis	0.00177	0.0232	CbGpPWpGaD
Bromazepam—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00177	0.00414	CcSEcCtD
Bromazepam—Mental disorder—Prednisone—ankylosing spondylitis	0.00176	0.00414	CcSEcCtD
Bromazepam—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00176	0.00413	CcSEcCtD
Bromazepam—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00175	0.00411	CcSEcCtD
Bromazepam—Malnutrition—Prednisone—ankylosing spondylitis	0.00175	0.00411	CcSEcCtD
Bromazepam—Convulsion—Betamethasone—ankylosing spondylitis	0.00174	0.00409	CcSEcCtD
Bromazepam—Convulsion—Dexamethasone—ankylosing spondylitis	0.00174	0.00409	CcSEcCtD
Bromazepam—GABRG2—Ion channel transport—ANO6—ankylosing spondylitis	0.00174	0.0228	CbGpPWpGaD
Bromazepam—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00169	0.00396	CcSEcCtD
Bromazepam—Vision blurred—Prednisone—ankylosing spondylitis	0.00165	0.00387	CcSEcCtD
Bromazepam—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00164	0.00385	CcSEcCtD
Bromazepam—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00164	0.00385	CcSEcCtD
Bromazepam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00162	0.0038	CcSEcCtD
Bromazepam—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00161	0.00378	CcSEcCtD
Bromazepam—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00161	0.00378	CcSEcCtD
Bromazepam—Agitation—Prednisone—ankylosing spondylitis	0.00161	0.00378	CcSEcCtD
Bromazepam—Tachycardia—Dexamethasone—ankylosing spondylitis	0.0016	0.00376	CcSEcCtD
Bromazepam—Tachycardia—Betamethasone—ankylosing spondylitis	0.0016	0.00376	CcSEcCtD
Bromazepam—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00159	0.00374	CcSEcCtD
Bromazepam—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00159	0.00373	CcSEcCtD
Bromazepam—Eye disorder—Methotrexate—ankylosing spondylitis	0.00157	0.00369	CcSEcCtD
Bromazepam—Anorexia—Betamethasone—ankylosing spondylitis	0.00157	0.00367	CcSEcCtD
Bromazepam—Anorexia—Dexamethasone—ankylosing spondylitis	0.00157	0.00367	CcSEcCtD
Bromazepam—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00156	0.00366	CcSEcCtD
Bromazepam—Fatigue—Triamcinolone—ankylosing spondylitis	0.00156	0.00366	CcSEcCtD
Bromazepam—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00156	0.00365	CcSEcCtD
Bromazepam—Hypotension—Betamethasone—ankylosing spondylitis	0.00153	0.0036	CcSEcCtD
Bromazepam—Hypotension—Dexamethasone—ankylosing spondylitis	0.00153	0.0036	CcSEcCtD
Bromazepam—GABRA1—Ion channel transport—ANO6—ankylosing spondylitis	0.00152	0.0199	CbGpPWpGaD
Bromazepam—Convulsion—Prednisone—ankylosing spondylitis	0.00152	0.00356	CcSEcCtD
Bromazepam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00149	0.0035	CcSEcCtD
Bromazepam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00149	0.00349	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00148	0.00348	CcSEcCtD
Bromazepam—Mental disorder—Methotrexate—ankylosing spondylitis	0.00147	0.00346	CcSEcCtD
Bromazepam—Malnutrition—Methotrexate—ankylosing spondylitis	0.00146	0.00344	CcSEcCtD
Bromazepam—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00145	0.0034	CcSEcCtD
Bromazepam—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00145	0.00339	CcSEcCtD
Bromazepam—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00145	0.00339	CcSEcCtD
Bromazepam—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00143	0.00335	CcSEcCtD
Bromazepam—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00143	0.00335	CcSEcCtD
Bromazepam—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00143	0.00335	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00142	0.00333	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00142	0.00333	CcSEcCtD
Bromazepam—Fatigue—Dexamethasone—ankylosing spondylitis	0.00142	0.00332	CcSEcCtD
Bromazepam—Fatigue—Betamethasone—ankylosing spondylitis	0.00142	0.00332	CcSEcCtD
Bromazepam—Nervous system disorder—Prednisone—ankylosing spondylitis	0.0014	0.00329	CcSEcCtD
Bromazepam—Tachycardia—Prednisone—ankylosing spondylitis	0.0014	0.00327	CcSEcCtD
Bromazepam—Skin disorder—Prednisone—ankylosing spondylitis	0.00139	0.00326	CcSEcCtD
Bromazepam—Vision blurred—Methotrexate—ankylosing spondylitis	0.00138	0.00324	CcSEcCtD
Bromazepam—Anorexia—Prednisone—ankylosing spondylitis	0.00136	0.0032	CcSEcCtD
Bromazepam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00135	0.00317	CcSEcCtD
Bromazepam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00135	0.00317	CcSEcCtD
Bromazepam—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00133	0.00313	CcSEcCtD
Bromazepam—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00133	0.00312	CcSEcCtD
Bromazepam—Dizziness—Prednisolone—ankylosing spondylitis	0.0013	0.00305	CcSEcCtD
Bromazepam—Asthenia—Triamcinolone—ankylosing spondylitis	0.0013	0.00305	CcSEcCtD
Bromazepam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0013	0.00304	CcSEcCtD
Bromazepam—Pruritus—Triamcinolone—ankylosing spondylitis	0.00128	0.003	CcSEcCtD
Bromazepam—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00128	0.003	CcSEcCtD
Bromazepam—Convulsion—Methotrexate—ankylosing spondylitis	0.00127	0.00298	CcSEcCtD
Bromazepam—Dyspepsia—Prednisone—ankylosing spondylitis	0.00126	0.00295	CcSEcCtD
Bromazepam—Decreased appetite—Prednisone—ankylosing spondylitis	0.00124	0.00292	CcSEcCtD
Bromazepam—Rash—Prednisolone—ankylosing spondylitis	0.00124	0.00291	CcSEcCtD
Bromazepam—Dermatitis—Prednisolone—ankylosing spondylitis	0.00124	0.00291	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00124	0.0029	CcSEcCtD
Bromazepam—Fatigue—Prednisone—ankylosing spondylitis	0.00123	0.00289	CcSEcCtD
Bromazepam—Headache—Prednisolone—ankylosing spondylitis	0.00123	0.00289	CcSEcCtD
Bromazepam—Confusional state—Methotrexate—ankylosing spondylitis	0.0012	0.00283	CcSEcCtD
Bromazepam—Dizziness—Triamcinolone—ankylosing spondylitis	0.0012	0.00281	CcSEcCtD
Bromazepam—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.0012	0.0028	CcSEcCtD
Bromazepam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00119	0.0028	CcSEcCtD
Bromazepam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00118	0.00276	CcSEcCtD
Bromazepam—Asthenia—Betamethasone—ankylosing spondylitis	0.00118	0.00276	CcSEcCtD
Bromazepam—Asthenia—Dexamethasone—ankylosing spondylitis	0.00118	0.00276	CcSEcCtD
Bromazepam—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00117	0.00275	CcSEcCtD
Bromazepam—Nausea—Prednisolone—ankylosing spondylitis	0.00117	0.00274	CcSEcCtD
Bromazepam—Pruritus—Dexamethasone—ankylosing spondylitis	0.00116	0.00273	CcSEcCtD
Bromazepam—Pruritus—Betamethasone—ankylosing spondylitis	0.00116	0.00273	CcSEcCtD
Bromazepam—Skin disorder—Methotrexate—ankylosing spondylitis	0.00116	0.00272	CcSEcCtD
Bromazepam—Vomiting—Triamcinolone—ankylosing spondylitis	0.00115	0.0027	CcSEcCtD
Bromazepam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00115	0.00269	CcSEcCtD
Bromazepam—Rash—Triamcinolone—ankylosing spondylitis	0.00114	0.00268	CcSEcCtD
Bromazepam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00114	0.00267	CcSEcCtD
Bromazepam—Anorexia—Methotrexate—ankylosing spondylitis	0.00114	0.00267	CcSEcCtD
Bromazepam—Rash—Methylprednisolone—ankylosing spondylitis	0.00114	0.00267	CcSEcCtD
Bromazepam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00114	0.00267	CcSEcCtD
Bromazepam—Headache—Triamcinolone—ankylosing spondylitis	0.00113	0.00266	CcSEcCtD
Bromazepam—Headache—Methylprednisolone—ankylosing spondylitis	0.00113	0.00265	CcSEcCtD
Bromazepam—Hypotension—Methotrexate—ankylosing spondylitis	0.00112	0.00262	CcSEcCtD
Bromazepam—Dizziness—Betamethasone—ankylosing spondylitis	0.00109	0.00255	CcSEcCtD
Bromazepam—Dizziness—Dexamethasone—ankylosing spondylitis	0.00109	0.00255	CcSEcCtD
Bromazepam—Nausea—Triamcinolone—ankylosing spondylitis	0.00107	0.00252	CcSEcCtD
Bromazepam—Nausea—Methylprednisolone—ankylosing spondylitis	0.00107	0.00252	CcSEcCtD
Bromazepam—Somnolence—Methotrexate—ankylosing spondylitis	0.00106	0.00249	CcSEcCtD
Bromazepam—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00105	0.00247	CcSEcCtD
Bromazepam—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00105	0.00247	CcSEcCtD
Bromazepam—Vomiting—Betamethasone—ankylosing spondylitis	0.00104	0.00245	CcSEcCtD
Bromazepam—Vomiting—Dexamethasone—ankylosing spondylitis	0.00104	0.00245	CcSEcCtD
Bromazepam—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00104	0.00244	CcSEcCtD
Bromazepam—Rash—Betamethasone—ankylosing spondylitis	0.00104	0.00243	CcSEcCtD
Bromazepam—Rash—Dexamethasone—ankylosing spondylitis	0.00104	0.00243	CcSEcCtD
Bromazepam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00103	0.00243	CcSEcCtD
Bromazepam—Dermatitis—Betamethasone—ankylosing spondylitis	0.00103	0.00243	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00103	0.00242	CcSEcCtD
Bromazepam—Fatigue—Methotrexate—ankylosing spondylitis	0.00103	0.00242	CcSEcCtD
Bromazepam—Headache—Dexamethasone—ankylosing spondylitis	0.00103	0.00241	CcSEcCtD
Bromazepam—Headache—Betamethasone—ankylosing spondylitis	0.00103	0.00241	CcSEcCtD
Bromazepam—Asthenia—Prednisone—ankylosing spondylitis	0.00103	0.00241	CcSEcCtD
Bromazepam—Pruritus—Prednisone—ankylosing spondylitis	0.00101	0.00237	CcSEcCtD
Bromazepam—GABRR1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.001	0.0131	CbGpPWpGaD
Bromazepam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000985	0.00231	CcSEcCtD
Bromazepam—Nausea—Betamethasone—ankylosing spondylitis	0.000975	0.00229	CcSEcCtD
Bromazepam—Nausea—Dexamethasone—ankylosing spondylitis	0.000975	0.00229	CcSEcCtD
Bromazepam—GABRR2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000954	0.0125	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000954	0.0125	CbGpPWpGaD
Bromazepam—Dizziness—Prednisone—ankylosing spondylitis	0.000946	0.00222	CcSEcCtD
Bromazepam—Vomiting—Prednisone—ankylosing spondylitis	0.000909	0.00213	CcSEcCtD
Bromazepam—Rash—Prednisone—ankylosing spondylitis	0.000902	0.00212	CcSEcCtD
Bromazepam—Dermatitis—Prednisone—ankylosing spondylitis	0.000901	0.00211	CcSEcCtD
Bromazepam—Headache—Prednisone—ankylosing spondylitis	0.000896	0.0021	CcSEcCtD
Bromazepam—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00088	0.00207	CcSEcCtD
Bromazepam—Asthenia—Methotrexate—ankylosing spondylitis	0.000857	0.00201	CcSEcCtD
Bromazepam—Nausea—Prednisone—ankylosing spondylitis	0.000849	0.00199	CcSEcCtD
Bromazepam—Pruritus—Methotrexate—ankylosing spondylitis	0.000845	0.00198	CcSEcCtD
Bromazepam—Dizziness—Methotrexate—ankylosing spondylitis	0.00079	0.00185	CcSEcCtD
Bromazepam—GABRG3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000786	0.0103	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000774	0.0101	CbGpPWpGaD
Bromazepam—Vomiting—Methotrexate—ankylosing spondylitis	0.00076	0.00178	CcSEcCtD
Bromazepam—Rash—Methotrexate—ankylosing spondylitis	0.000753	0.00177	CcSEcCtD
Bromazepam—Dermatitis—Methotrexate—ankylosing spondylitis	0.000753	0.00177	CcSEcCtD
Bromazepam—Headache—Methotrexate—ankylosing spondylitis	0.000749	0.00176	CcSEcCtD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000733	0.0096	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000723	0.00948	CbGpPWpGaD
Bromazepam—Nausea—Methotrexate—ankylosing spondylitis	0.00071	0.00167	CcSEcCtD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000662	0.00867	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00065	0.00852	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000643	0.00842	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000631	0.00827	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00062	0.00813	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000616	0.00807	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000605	0.00793	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000529	0.00693	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000467	0.00612	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000449	0.00588	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000323	0.00423	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000321	0.00421	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.00013	0.0017	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.00013	0.0017	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000122	0.0016	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	7.37e-05	0.000966	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	5.69e-05	0.000745	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	4.43e-05	0.000581	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	3.42e-05	0.000448	CbGpPWpGaD
